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Despite the prevalence and recognition of its detrimental impact, clinical complications
of sepsis remain a major challenge. Here, we investigated the effects of myeloid ferritin
heavy chain (FtH) in regulating the pathogenic sequelae of sepsis. We demonstrate
that deletion of myeloid FtH leads to protection against lipopolysaccharide-induced
endotoxemia and cecal ligation and puncture (CLP)-induced model of sepsis as
evidenced by reduced cytokine levels, multi-organ dysfunction and mortality. We
identified that such protection is predominantly mediated by the compensatory increase
in circulating ferritin (ferritin light chain; FtL) in the absence of myeloid FtH. Our in vitro
and in vivo studies indicate that prior exposure to ferritin light chain restrains an otherwise
dysregulated response to infection. These findings are mediated by an inhibitory action of
FtL on NF-κB activation, a key signaling pathway that is implicated in the pathogenesis of
sepsis. We further identified that LPSmediated activation of MAPK pathways, specifically,
JNK, and ERK were also reduced with FtL pre-treatment. Taken together, our findings
elucidate a crucial immunomodulatory function for circulating ferritin that challenges the
traditional view of this protein as a mere marker of body iron stores. Accordingly, these
findings will stimulate investigations to the adaptive nature of this protein in diverse clinical
settings.
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INTRODUCTION
Sepsis is a severe, dynamic, and deranged immune response to an infectious insult (1, 2). The
complexity of this clinical syndrome is perhaps best highlighted by its evolving definitions (3, 4).
The most recent international consensus defines sepsis as life-threatening organ dysfunction
resulting from a dysregulated host response to infection (4). The overall mortality rates of sepsis
are alarmingly high and range from 10 to 50% of diagnosed patients with development of organ
injury and septic shock as two major factors leading to higher mortality rates (5–7). Consequently,
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the massive burden of morbidity, mortality, and healthcare
expenditure associated with sepsis underscore the desperate
need for gaining more insight into this devastating clinical
syndrome and identifying novel targets for prevention and
therapy. Discovery of penicillin by Sir Alexander Fleming was a
major defining moment in human history and its struggle against
infections. Nevertheless, despite vigorous investigations, overall
improvement in our understanding of themolecularmechanisms
involved in the pathogenesis of sepsis and numerous clinical
trials, an “anti-sepsis” drug remains elusive (8, 9).
Ferritin is a spherical protein made of 24 subunits (10).
These subunits are composed of heavy (FtH) and light (FtL)
chains and their proportional contribution to the hollow
spherical shell varies among tissues. Ferritin was traditionally
considered to be a cytosolic protein with the mere function
of iron storage. However, our understanding of this highly
evolutionarily-preserved molecule has dramatically advanced in
the past couple of decades. It is now clear that within the
subcellular compartments, ferritin is present in the mitochondria
and nucleus (11–13). Additionally, several functions other than
iron storage including immunomodulatory attributes have been
described [reviewed in (14, 15)]. Another interesting aspect of
ferritin in the context of biological activity relates to serum
ferritin. The precise source of serum ferritin was long debated.
However, in an elegant study Cohen et al. revealed that serum
ferritin is mainly a secreted protein, involving a non-classical
lysosomal pathway (16). Furthermore, it was shown that FtL is
the main form of circulatory protein, its iron content is low
and more importantly, macrophages are the main source of
serum ferritin (16). Serum ferritin level has been utilized by
clinicians as part of a panel to assess iron stores. However, serum
ferritin is also increased in response to infections, inflammation
and malignancy and is generally accepted to be an acute
phase reactant similar to C-reactive protein (17, 18). Despite
this knowledge and our evolving understanding of the well-
orchestrated pathways involved in cellular and systemic iron
homeostasis, the precise role of serum ferritin and its impact on
disease progression is yet to be conspicuously defined. While the
connotation of iron’s role in infection is extensively debated, lack
of consistent evidence precludes us to comprehensively define the
paradigm of such relationship and more importantly how serum
ferritin may be involved in this context. Here, we asked whether
myeloid cell specific FtH deletion modulates inflammation and
organ injury in a commonly used and well-established model of
poly-microbial sepsis, cecal ligation and puncture (CLP).
MATERIALS AND METHODS
Experimental Model and Subject Details
Male and female H-ferritin floxed mice (FtHfl/fl) and myeloid-
specific H-ferritin deletion mice (FtHLysM−/−) (10–14 weeks of
age), previously described (19, 20), were used in this study.
FtHfl/fl mice were generated on a mixed background (C57BL/6
× 129/Sv) and were backcrossed to C57BL/6 for 10 generations.
LyzMCre mice were generated on a mixed background (Sv129
× C57BL/6 × CB.20) but were backcrossed to a C57BL/6
background for six generations before submission to Jackson
Laboratories (Jackson Laboratories; stock 004781). Myeloid-
specific FtH deletion mice on a C57BL/6 background were
obtained by breeding FtHfl/fl and LyzMCre mice. All mice
were treated humanely and methods were approved by the
Institutional Animal Care and Use Committee of UAB. Studies
were performed in accordance with National Institutes of Health
guidelines.
Cecal Ligation and Puncture-Induced
Sepsis
Mice were anesthetized with isoflurane (1.5–2% isoflurane
induction, 1–1.5% maintenance). Midline laparotomy incision
(1–2 cm) was made under aseptic conditions to expose the
cecum, and stool was milked to the tip and ligated 0.7 centimeter
from the tip. Using a 21G needle, two punctures were made
in the cecal wall and fecal material was expressed in to the
peritoneal cavity. The cecum was placed back in the peritoneal
cavity and musculature and skin were sutured. Sham animals
underwent laparotomy and bowel manipulation without ligation
or perforation. Mice were placed on a heating pad for recovery
and provided unrestricted access to water and food. Mice were
monitored closely for signs and symptoms of pain and distress
(usually developed 6–12 h after surgery). Mice were sacrificed
8 and 24 h after surgery. Serum was collected for creatinine
measurement by LC-MS/MS. Endotoxin-free recombinant FtL
(1mg per 25 g B.W.) was administered intravenously 24 h prior
to CLP surgery.
Lipopolysaccharide (LPS)-Induced Sepsis
Mice were anesthetized with isoflurane 1.5–2% isoflurane
induction, 1–1.5% maintenance and injected intraperitoneally
with 8 mg/kg LPS (Invivogen) and were sacrificed 24 h after




Blood pressure was recorded and analyzed via left carotid
artery PA-C10 telemetry implant (DSI, Saint Paul, MN), as
previously described (21, 22). Sepsis was induced by CLP after
baseline measurements were performed and blood pressure
was monitored. The device implantation and monitoring were
performed by the UAB-UCSD O’Brien Center Core Facility.
Transcutaneous GFR Measurement
Transcutaneous GFR was measured in mice using fluorescein
isothocyanate (FITC)-labeled sinistrin (MediBeacon), as
previously described (23). GFR was monitored for 2 h, after
which the monitors were removed and data were analyzed using
elimination kinetics curve of sinistrin clearance, as previously
described (24).
Measurement of Serum Cytokine Levels
Mouse serum cytokine levels were measured using mouse V-
PLEX Pro-inflammatory Panel I Kit (Meso Scale Discovery),
following manufacturers recommendations. Data was acquired
using a MESO Sector S600 plate reader (Meso Scale Discovery).
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Cytokine levels were represented as picograms or nanograms per
milliliter.
Flow Cytometry
Mice were anesthetized with 1.5–2% isoflurane and blood
was collected using cardiac puncture. Organs were perfused
with cold PBS and spleen was harvested and weighed. Flow
cytometry was performed as described previously (20, 25).
Following antibodies (with their respective clone numbers) were
obtained from eBioscience unless otherwise stated: 7-AAD,
MHCII-FITC (M5/114.15.2), Gr-1-APC (1A8), Ly6C-eF450
(HK1.4), CD11b-SuperBright600 (M1/70), CD45.2-BV650 (104;
BioLegend), F4/80-APC-eF780 (BM8), CD11c-BV785 (N418;
BioLegend), NK1.1-PE (PK136), CD3e-APC (145-2C11), CD8a-
eF450 (53-6.7), CD4-SuperBright600 (RM4-5), CD19-BV785
(6D5; BioLegend). AccuCheck beads (Life Technologies) were
used to determine absolute numbers by normalizing to tissue
mass. Data were collected with a Becton-Dickinson LSRII
analyzer and analyzed using FlowJo software (Trecstar Software).
Peritoneal Colony Forming Unit (CFU)
Measurement
Mice were anesthetized with 1.5–2% isoflurane and peritoneal
lavage was sterilely collected in 0.9% sterile saline. Serial dilutions
of the peritoneal lavage fluid were made and plated on Trypticase
Soy Agar with Sheep Blood (Fisher Scientific). Agar plates were
incubated at 37◦C for 24 h. Single colonies were counted and data
were represented as CFU per milliliter.
In vitro Phagocytosis
Bone marrow-derived macrophages (BMDMs) were changed
to DMEM + 1% FBS media 24 h before being treated
with LPS (100 ng/mL) or Apoferritin (0.1 mg/mL; Sigma).
BMDMs were harvested and stained with CD11b-APC
(M1/70; eBioscience), 7AAD (eBioscience). Cells were
simultaneously incubated with MOI 10 pHrodo Red Escherichia
coli BioParticles (ThermoFisher), as previously described
with minor modifications (26). Cells were analyzed on a BD
FACSCalibur and data was analyzed using FlowJo software.
Bacterial Propagation
Xen14 (bioluminescent Escherichia coli WS2572 parent strain,
Perkin Elmer) was cultured overnight in an orbital shaker at 200
rotations per minute at 37◦C in Luria Broth medium containing
30µg/mL kanamycin (Fisher Scientific). Initial absorbance
was determined at 600 nm and dilutions were prepared with
antibiotic-free DMDM+ 1% FBS for all experiments.
In vitro Bacterial Killing
Bone marrow-derived macrophages (BMDMs) were changed to
DMEM + 1% FBS media 24 h before this assay. Absorbance
of cultured Xen14 was determined at 600 nm and dilutions
were prepared in antibiotic-antimycotic free cell culture media.
BMDMs were treated with MOI 10 or 100 for 30min. Bacterial
media was aspirated and BMDMs were washed with PBS. DMEM
+ 1% FBS + 200µg/mL gentamicin was added for 2 h and
luminescence quantified on a Biotek Synergy HT plate reader.
Data were expressed as arbitrary units (AU) of luminescence.
In vivo Bacterial Killing
Absorbance of cultured Xen14 was determined and dilutions
were prepared in 0.9% sterile normal saline. The abdomen of
the mice was shaved and injected intraperitoneally with 106
Xen14. Mice were immediately imaged using a Xenogen IVIS-50
Bioluminescence Reader, housed by the UAB Preclinical Imaging
Shared Facility. Mice were imaged at 2, 4, 8, and 24 h after
injection. Data were expressed as mean fluorescence index in AU.
Cecal Slurry Preparation
Cecal slurry was collected from male wild-type mice, as
previously described (27). Equal volume of 30% glycerol in sterile
PBS was added, then cecal slurry was aliquoted in to cryovials for
storage at−80◦C.
Purification of Recombinant Human FtL
Recombinant human FtL was generated as previously described
(28). Briefly, FtL was expressed in E. coli using a pDS20pTrp
vector. Gel purification was performed on a Sepharose 6B
column, followed by a DEAE column. Endotoxin was removed
using Pierce High Capacity Endotoxin Removal Spin Columns
(ThermoFisher), per manufacturer protocol. Electrophoretic
purity was determined (96% pure) and removal of endotoxin was
confirmed using an E-Toxate kit (Sigma). Apoferritin derived
from equine spleen was bought from Sigma (A3641).
Cell Culture
Bone marrow-derived macrophages (BMDMs) were isolated
from FtHfl/fl and FtHLysM−/− mice, as previously described, with
minor modifications (20). BMDMs were cultured for 6 days
before experiments were performed. BMDMs were plated onto
culture dishes and treated with L-ferritin, or Apoferritin (0.1
mg/ml) for 16 h. Media was removed, the cells were washed with
PBS and treated with LPS (100 ng/mL) or cecal slurry (1 µL
per one million cells) in DMEM + 1% FBS for the indicated
times. Cells were then washed with PBS and collected for RNA
or protein analysis.
Quantification of mRNA Expression
Gene expression analysis was performed, as previously described
(29). Primers used to detect the specific genes are listed in
Table S4. For the RNA sequencing studies, total RNAwas isolated
from blood via cardiac puncture using a Blood RNA isolation
kit (ThermoFisher Scientific) and subsequently, globin mRNA
was depleted using GLOBINclear kit (ThermoFisher Scientific).
RNA was sequenced on NextSeq500 system and the library was
prepared with the Agilent SureSelect Stranded mRNA kit.
Western Blot
All western blotting was performed as previously described (20).
Membranes were blocked according to manufacturer’s protocol
(5% non-fat dry milk in TBST or 5% BSA in TBST) for
1 h and incubated with a mouse p-P65 (Santa Cruz, 1:1,000),
rabbit total P65 (Cell Signaling, 1:2,000), mouse FtH (Santa
Cruz, 1:1,000), mouse FtL (Santa Cruz, 1:1,000), or goat FtL
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(Thermofisher or Santa Cruz, 1:1,000), followed by a peroxidase-
conjugated goat anti-mouse or goat anti-rabbit or donkey
anti-goat IgG antibody (Jackson ImmunoResearch Laboratories,
1:10,000). Horseradish peroxidase activity was detected using
chemiluminescence (GE Healthcare) or KwikQuant detection
system or LI-COR infraredOdyssey Imaging System.Membranes
were stripped and reprobed with anti-GAPDH (Sigma-Aldrich,
1:10,000) or anti-β-actin (Sigma-Aldrich, 1:10,000) as a loading
control. Densitometry analysis was performed using ImageStudio
Lite and results were normalized to GAPDH or total P65
expression. Data were represented as fold change over controls.
Blood Collection, Serum Preparation, and
Analysis
Mice were anesthetized with 1.5–2% isoflurane and blood
was collected by intra-cardiac puncture. Serum was isolated
from blood after 30-min room temperature incubation and
centrifugation. Aspartate transaminase activity (BioAssay
Systems), HMGB1 (LSBio), iron (Abcam), hepcidin
(eLabScience), NGAL (ENZO Life Sciences), hemopexin
(Alpha Diagnostic), haptoglobin (Alpha Diagnostic), and ferritin
(Kamiya Biomed) were measured in the serum according to
manufacturers’ protocols.
HISTOLOGY
Organs were collected and fixed in 10% neutral buffered formalin
for 16 h prior to paraffin embedding. Paraffin sections were cut in
to 4µm sections, deparaffinized, and rehydrated using CitriSolv
and isopropanol. Tissues were stained with hematoxylin and
eosin stain using standard protocol. All images were acquired
using a Leica DMI 6000B microscope (Leica Microsystems) and
Leica Application Suite V4.2 software.
RNA Sequencing Data Processing and
Analysis
Raw sequencing (fastq) files were subjected to quality control
analysis using FastQC (v0.11.5) [http://www.bioinformatics.
babraham.ac.uk/projects/fastqc/] and using Trim Galore
(v0.4.1) [http://www.bioinformatics.babraham.ac.uk/projects/
trim_galore/], adapter sequences and poor quality reads were
trimmed. Trimmed and cleaned sequence reads were aligned to
mouse genome (GRCm38) using TopHat v2.1.0 (30) or STAR
v2.5.3.a (31). The accepted BAM files from TopHat were sorted
using samtools (Version: 1.3.1) (32) and reads aligning each
annotated mouse gene were enumerated using HTSeq-count
(33).
Differential expression analysis was performed using DESeq2
(34), following standard protocol [https://bioconductor.org/
packages/release/bioc/vignettes/DESeq2/inst/doc/DESeq2.
html]. Genes altered by absolute fold change of two or
more with adjusted p-value < 0.01 were considered to be
significantly differentially expressed [DEG]. DAVID (Database
for Annotation, Visualization and Integrated Discovery) version
6.8 (35) was then used to conduct Gene Ontology (GO) and
KEGG pathway enrichment analysis on DEG. Heatmap figures
were generated in R 3.2.2 (https://cran.r-project.org/) using




Data are represented as mean ± SEM. Unpaired 2-tailed t-test
was used for comparisons between two groups. ANOVA and
Tukey’s multiple comparisons tests were used for comparisons
between more than two groups. Survival significance was
determined by Kaplan–Meier curve and log rank test. P < 0.05
were considered significant. All analysis was performed using
GraphPad Prism 7.
DATA AVAILABILITY
The accession numbers for the RNA sequencing data reported in
this paper are Gene Expression Omnibus (GEO): GSE114078.
CONTACT FOR REAGENT AND
RESOURCE SHARING
Further information and requests for resources and reagents
should be directed to and will be fulfilled by the corresponding
author, Subhashini Bolisetty (sbolisetty@uabmc.edu).
RESULTS
Myeloid FtH Deficiency Prevents
Multi-organ Failure and Mortality in
Experimental Sepsis
Following CLP, wild-typemice (FtHfl/fl) succumbed to significant
mortality within 72 h following surgery whereas mice deficient
in myeloid FtH (FtHLysM−/−) displayed significantly improved
survival that was independent of gender (Figures 1A,B). Two
important life-threatening attributes of sepsis are related to
organ dysfunction and septic shock. Accordingly, we assessed
the extent of organ injury following CLP and determined
that myeloid FtH deficiency was associated with significantly
improved preservation of renal function as evidenced by
serum creatinine (Figure 1C) and transcutaneous glomerular
filtration rate measurement (Figure 1D), lesser hepatic injury
(AST, Figure 1E), and preserved circulatory status when
compared to FtHfl/fl mice (mean arterial pressure, systolic
and diastolic blood pressure, Figures 1F–I). Additionally,
structural damage to the lung and liver was less prominent,
as confirmed by histological analyses (Figure S1). These
findings suggest that FtH deficiency in the myeloid cells
is associated with defense against sepsis induced organ
dysfunction.
Myeloid FtH Deficiency Dampens the
Inflammatory Response in Sepsis
A dysregulated hyperinflammatory immune response is a
hallmark of sepsis. In this context, we next assessed the levels
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FIGURE 1 | Myeloid FtH deficiency prevents multi-organ failure and mortality in experimental sepsis. (A,B) Percent survival of mice deficient in myeloid-specific FtH
(FtHLysM−/−) and their floxed controls (FtHfl/fl) after cecal ligation puncture (CLP) surgery. (A) Males, n = 11 per group. (B) Females, n = 7–12 per group. Data are
from three independent experiments; #p < 0.05 vs. FtHfl/fl. (C) Serum creatinine levels were measured and expressed in milligrams per deciliter (mg/dL) as mean ±
SEM 24h after CLP or sham surgeries. Sham, n = 3 per group; CLP, n = 10 per group. *p < 0.05 vs. sham. (D) Transcutaneous glomerular filtration rate (GFR) was
measured using FITC-sinistrin 24 h after CLP or sham surgery and expressed in microliters per minute (µL/min) as mean ± SEM. Sham, n = 3 per group; CLP, n = 10
per group. *p < 0.05 vs. sham. (E) Serum aspartate aminotransferase (AST) was measured 24 h after CLP surgery and expressed in units per liter (U/L) as mean ±
SEM. Sham, n = 5–6 per group; CLP, n = 12 per group. *p < 0.05 vs. sham (F–I). (F) Blood pressure was measured using radiotelemetry. Baseline measurements
were recorded 24 h prior to CLP. Mice were monitored for 48 h. (G) Mean arterial pressure, (H) systolic, and (I) diastolic blood pressure were recorded 24 h following
CLP in FtHLysM−/− and FtHfl/fl controls and expressed as mean ± SEM. n = 6 per group; *p < 0.05 vs. sham.
of cytokines in the sera of mice that underwent sham or
CLP surgery. In accordance with organ dysfunction in the
FtHfl/fl mice, 24 h after CLP surgery, there was a significant
increase in the levels of cytokines that have been implicated
in the pathogenesis of sepsis, including the pro-inflammatory
cytokines, TNF-α, IFN-γ, IL-6, IL-12, CXCL1, IL-1β, and IL-
2 (Figure 2). In contrast, FtHLysM−/− mice displayed a non-
significant increase in the levels of these cytokines when
compared to sham controls. This response was also associated
with a lack of significant induction in the anti-inflammatory
cytokines such as IL-4 and IL-10 and had no apparent difference
in the expression of IL-5, a cytokine that is predominantly
produced by non-myeloid cells such as mast cells and T
cells.
To assess the cross-talk between parenchymal and immune
cells, we next analyzed several well-established markers of
inflammation. Figure S2 depicts the expression profile of pro-
inflammatory and anti-inflammatory cytokines and chemokines
in the organs of myeloid FtH-deficient mice compared to
their floxed wild-type controls that underwent sham or sepsis.
Whether such regulation is contributed by the parenchymal
cells or the resident myeloid cells within these organs is
currently unknown. As expected, we found that splenic FtH
induction following CLP was blunted in the FtHLysM−/− mice
(Figure S2). However, we did not find any association of
FtH expression and cytokine levels in the organs following
CLP. Expression of Heme oxygenase-1 (HO-1), an anti-oxidant
enzyme with potent anti-inflammatory properties, was not
significantly different following CLP in the organs of FtHfl/fl
compared to FtHLysM−/− mice, suggesting that the protective
effects of myeloid FtH deletion were independent of HO-1
(Figure S2).
We next characterized the profile of immune cell populations
in the blood, spleen and lung to determine whether the
protective effect of myeloid FtH deficiency is secondary to its
role in regulating inflammation (Figures 3A,B and Figure S3A).
Corroborating previous reports, we demonstrate that sepsis
results in marked leukopenia in mice, leading to reduced
CD45+ hematopoietic cells (Figure 3C) (36). More specifically,
there was a significant reduction in the number of neutrophils
in the blood and spleen following CLP in both FtHfl/fl and
FtHLysM−/− mice. Interestingly, there was no difference in
monocytes/macrophages (MM) (Figure 3C) or inflammatory
MM (as defined by expression of Ly6Chi and CX3CR1+CCR2+
macrophages) (Figure S3B). In support of previous reports, there
is a significant reduction in peripheral as well as splenic T
cells (CD3+), and specifically a decrease in cytotoxic CD8+
T cells following CLP in both the myeloid-ferritin knockout
mice and controls (Figure 3C) (37–39). We also found a similar
trend in the reduction of B cells following CLP (Figure 3C).
In the spleen, we demonstrate a decrease in neutrophils and
inflammatory macrophages (Ly6Chi and CX3CR1+CCR2+),
but no difference in the total macrophage, dendritic cell or
lymphoid cell populations (Figure 3D and Figure S3C). We
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FIGURE 2 | Myeloid FtH deficiency dampens the inflammatory response
during sepsis Serum levels of tumor necrosis factor-α (TNF-α), interferon-γ
(IFN-γ), interleukin-6 (IL-6), IL-12, chemokine ligand 1 (CXCL1), IL-10, IL-1β,
IL-4, IL-2, and IL-5 were measured 24 h following sham or CLP surgery. Data
are expressed in nanograms or picograms per milliliter (ng/mL or pg/mL) as
mean ± SEM. Sham, n = 7 per group; CLP, n = 9–11 per group. Data are from
two independent experiments. *p < 0.05 vs. sham, #p < 0.05 vs. FtHfl/fl.
further demonstrate that while there was a significant increase
in the proportion of macrophages, there was no significant
difference in the neutrophil or dendritic cell populations in lungs
of both the transgenic mice following CLP compared to sham
(Figure S3D). Taken together, there was no significant difference
in the lymphoid and myeloid populations following sepsis in the
FtHfl/fl vs. FtHLysM−/− mice.
FtH Expression Does Not Influence
Phagocytosis or Bacterial Clearance
We next investigated whether the dampened cytokine response
in the mice incompetent of FtH expression in the myeloid
compartment was due to a difference in bacterial load or an
inability of myeloid cells to detect, phagocytose, and clear
bacteria. As evident from Figure S4A, there was no difference
in the bacterial load in the peritoneal lavage of FtHLysM−/− vs.
FtHfl/fl mice at 24 h following CLP. We also assessed the effect of
myeloid FtH deficiency on bacterial clearance in vivo. Following
intraperitoneal administration of chemiluminescent E. coli strain
Xen 14, real-time IVIS imaging revealed no difference in bacterial
clearance in FtHLysM−/− vs. FtHfl/fl mice (Figure S4B). These
findings were further corroborated in vitro with infection of
BMDMs with Xen 14 (Figure S4C). Additionally, there was no
significant difference in the phagocytic ability of myeloid FtH
deficient BMDMs compared to wild-type BMDMs (Figure S4D).
These results effectively rule out any attributable function
of myeloid FtH in the context of bacterial recognition or
phagocytosis by macrophages.
Myeloid FtH Deletion Diminishes Response
to Lipopolysacharide
To further determine whether FtH expression regulates the
response to lipopolysaccharide (LPS), a potent endotoxin that
is implicated in the pathogenesis of gram-negative bacterial
induced sepsis, we administered LPS to wild-type and myeloid
FtH deficient mice. While FtHfl/fl mice exhibited a significant
loss of kidney function, FtHLysM−/− mice were resistant to LPS-
induced kidney injury (Figure 4A). Upon further investigation,
we demonstrate that while LPS-induced IL-6 and IL-1β
expression were significantly lower in FtHLysM−/− macrophages
compared to FtHfl/fl macrophages, a non-significant trend
was observed for TNF-α and NLRP3 mRNA expression
(Figures 4B–F).
Absence of FtH Led to Blunted Activation
of NF-κB Following LPS
We next addressed whether the protective effects of FtH deletion
are related to the regulation of nuclear factor kappa-light-
chain enhancer of activated B cells (NF-κB; p65), a principal
determinant of sepsis mediated injury (40). We demonstrate that
LPS induced a time-dependent increase in the phosphorylation
of p65 in FtHfl/fl macrophages, an effect that was remarkably
blunted in the FtHLysM−/− cells (Figure 4H). We further
evaluatedmacrophages for the expression of phosphorylated JNK
and ERK, two key MAPK pathways that are activated following
LPS stimulation. In corroboration with previous studies, absence
of FtH led to an increase in LPS-induced phosphorylation of JNK
(41) and ERK kinase (Figures 4H,I). Interestingly, we observed
a bi-phasic activation of ERK following LPS stimulation, the
latter activation is possibly driven by cytokines. As previously
reported, lack of FtH in the macrophages from FtHLysM−/− mice
was associated with a compensatory increase in the levels of FtL
(Figure 4G) (20).
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FIGURE 3 | Myeloid FtH deficiency dampens the inflammatory response without altering the proportions of immune cell populations. (A,B) Representative flow
cytometry histograms of (A) myeloid and (B) lymphoid panels from FtHfl/fl sham control spleen demonstrating gating scheme and proportions of immune cell
populations. (C,D) Quantification of number of cells in the (C) blood and (D) spleen 24 h after CLP. Data are from three independent experiments and are represented
as number of cells per gram spleen (cells/g) or number of cells per ml blood as mean ± SEM. n = 4–5 per group. *p < 0.05 vs. sham.
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FIGURE 4 | Myeloid FtH deletion diminishes response to lipopolysaccharide (LPS). (A) Serum creatinine levels were measured and expressed in mg/dL as mean ±
SEM 24h after LPS (8 mg/kg) or vehicle (normal saline). n = 5 per group; #p < 0.05 vs. FtHfl/fl. (B–G) Real-time polymerase chain reaction (RT-PCR) analysis of
mRNA expression of (B) FtH, (C) TNF-α, (D) IL-6, (E) NACHT, LRR, and PYD domains-containing protein (NLRP3), and (F) IL-1β in bone marrow-derived
macrophages (BMDMs) of FtHfl/fl and FtHLysM−/− mice that were treated with vehicle or LPS for 8 h. Data are analyzed and represented relative to GAPDH as mean
± SEM. n = 5–6 per group; *p < 0.05 vs. vehicle, #p < 0.05 vs. FtHfl/fl. (G) Untreated BMDMs from FtHfl/fl and FtHLysM−/− mice were analyzed for expression of
FtH and FtL. Membranes were stripped and reprobed for GAPDH expression to demonstrate equal loading. (H,I) BMDMs from FtHfl/fl and FtHLysM−/− mice were
collected at 0, 0.25, 0.5, 1, 2, 4, and 8 h after LPS treatment and analyzed for expression of (H) phosphorylated p65 (pP65), total P65, phosphorylated extracellular
signal-related kinase (pERK), FtH, and (I) phosphorylated c-Jun N-terminal kinase (pJNK), total JNK, and FtH. GAPDH was used as a loading control. Total ERK levels
were examined in these lysates on a different membrane. Representative western blots from one out of three mice per genotype.
Serum Ferritin Is Significantly Higher in the
Myeloid FtH Deficient Mice
At 24 h following CLP, there was no significant difference in
the levels of high mobility group box 1 (HMGB1), a potential
mediator of pathogenic events in sepsis (Figure 5A). HMGB1
is also implicated in leukocyte apoptosis and therefore may
contribute to the significant decrease in leukocyte populations
following CLP in both transgenic mice (Figure 3C). While serum
iron levels were not different between sham-operated animals,
CLP led to a significant reduction in serum iron levels in both the
transgenic groups (Figure 5B). Additionally, serum iron levels
were significantly higher in the FtHLysM−/− mice that underwent
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CLP compared to FtHfl/fl mice. As expected, hepcidin, an anti-
microbial peptide, and a master regulator of iron homeostasis,
was significantly higher in both the FtHLysM−/− and FtHfl/fl mice
after CLP when compared to their respective sham controls.
However, hepcidin levels were significantly lower in FtHLysM−/−
mice compared to FtHfl/fl mice that underwent CLP (Figure 5C),
which may explain the higher serum iron levels in FtHLysM−/−
mice following CLP. Furthermore, while neutrophil gelatinase-
associated lipocalin (NGAL), another iron chelating protein
with anti-bacterial properties, was significantly increased after
CLP surgery, there was no significant difference attributed to
myeloid FtH expression (Figure 5D). These results suggest that
iron regulatory proteins, hepcidin and NGAL, do not account
for the observed protective response in myeloid FtH deficient
mice.
Hemolysis and resultant heme burden are implicated in
the pathogenesis of sepsis (42). In fact, administration of
hemopexin to quench free heme prevents sepsis injury in
rodent models (42, 43). While we observed that hemopexin
was significantly higher in mice that underwent CLP surgery,
there was no influence of myeloid FtH on circulating hemopexin
levels (Figure 5E). Haptoglobin, a protein that binds free
hemoglobin is protective against sepsis pathogenesis and has
been shown to decrease in the acute phase after sepsis (44, 45).
We observed a significant reduction in serum haptogloboin
levels 8 h after CLP, which was not different between FtHfl/
and FtHLysM−/− mice (data not shown). However, we found
significantly higher levels of haptoglobin at 24 h following CLP
in the serum of FtHLysM−/− when compared to FtHfl/fl mice
(Figure 5F).
We next investigated whether levels of serum ferritin, mainly
comprised of ferritin light chain (FtL), were differentially
regulated in the absence of myeloid FtH expression.
Interestingly, we found that serum ferritin levels were
significantly higher in the FtHLysM−/− mice compared to
FtHfl/fl mice. Furthermore, we observed a significant increase
in ferritin levels in mice that underwent CLP (irrespective of
their myeloid FtH status) when compared to sham surgery
(Figure 5G).
FtL Confers Protection Against
Sepsis-Induced Hyperinflammation and
Organ Dysfunction
To investigate whether increased serum ferritin levels offered
resistance to sepsis, we administered recombinant FtL to FtHfl/fl
mice, performed CLP surgery and measured the levels of
inflammatory cytokines in the serum after 24 h (Table S1). We
demonstrate a significant inhibitory effect on serum cytokine
production in the presence of FtL following CLP surgery.
Additionally, we also found that FtL administration led to
significantly lesser hepatic injury as evidenced by AST (FtL
CLP: 144 ± 9.4 vs. Vehicle CLP: 219 ± 16.8 U/L; p <
0.001). These findings suggest that FtL is associated with
defense against sepsis-induced hyperinflammation and organ
dysfunction.
FtL Mitigates LPS-Induced MAPK and
NF-κB Activation in Macrophages
Pre-treatment of BMDMs with FtL led to significantly lower
induction of expression of inflammatory markers (IL-6, IL-
1β, TNF-α, MCP-1) and inducible nitric oxide synthase (iNOS;
Figure 6A). Pre-treatment with apoferritin, a holosphere that
contains equal proportions of FtH and FtL, yielded similar
results (Figure S5A). Pre-treatment with FtL led to reduced
activation of LPS-mediated phosphorylation of JNK and ERK
(Figure 6B). Additionally, pre-treatment with apoferritin also led
to reduced phosphorylation of JNK when compared to vehicle
treated cells (Figure 6D). These JNK activation data contrast our
findings in LPS treated FtHLysM−/− macrophages (Figure 4I),
suggesting a cumulative effect of FtH and FtL expression on
mitigating JNK activation. LPS treatment activates the NF-
κB pathway (Figure 4), therefore, we determined whether FtL
regulates NF-κB activation. Interestingly, we demonstrate that
pre-treatment with FtL or apoferritin mitigates LPS-induced
phosphorylation of p65 (Figures 6C,D). In addition, we found
that LPS-mediated degradation of IκBα was markedly less
pronounced in macrophages that were pre-treated with FtL or
apoferritin (Figures 6C,D). Of note, we found that treatment
with FtL led to an increase in expression of FtH expression.
Also, phosphorylated p65 levels were significantly lower in the
spleens of FtHLysM−/− mice compared to FtHfl/fl mice following
CLP (Figures S5C–E). Taken together these data suggest that
FtL diminishes NF-κB activation and downstream inflammatory
response and confers resistance to sepsis.
To mimic the polymicrobial flora of our in vivo model, we
prepared cecal slurry from FtHfl/fl mice as previously described
(27). Our data demonstrated that pre-treatment with apoferritin
led to an abated immune response in the presence of cecal
slurry (Figure S5B). Specifically, induction of IL-6, MCP-1, TNF-
α, and IL-1β was markedly lower in the presence of apoferritin.
Corroborating our previous findings, we demonstrate that
apoferritin treatment induced expression of iNOS (Figure S5B)
(20).
Alteration of Gene Expression Profile of
Blood Leukocytes Following Sepsis
We next performed transcriptomic analyses of blood leukocytes
from FtHLysM−/− and FtHfl/fl mice following sham or CLP
surgery. The heatmap shown in Figure 7A highlights the
significant (p < 0.01) differential expression of transcripts
following CLP in both the transgenic mice compared to sham
controls. Corroborating our cytokine data, we found that CLP
led to enrichment of biological processes that are associated
with an immune response (Tables S2, S3). Interestingly, in
comparison with FtHfl/fl, CLP induced transcriptomic changes in
the FtHLysM−/− mice demonstrated a clear pattern of dampened
immune response. These include downregulation of genes
associated with processes such as the inflammatory response, the
response to LPS and cell proliferation (Table S2). Additionally,
genes associated with processes such as oxidant detoxification
and regulation of NF-κB signaling were upregulated in the
myeloid FtH deficient mice (Table S3). Hierarchical clustering of
Frontiers in Immunology | www.frontiersin.org 9 February 2019 | Volume 10 | Article 131
Zarjou et al. Ferritin Mitigates Sepsis-Mediated Pathogenic Sequelae
FIGURE 5 | Serum ferritin is significantly higher in myeloid FtH deficient mice. Serum from FtHfl/fl and FtHLysM−/− mice 24 h after CLP and sham surgeries was
collected and analyzed for (A) high mobility group box-1 (HMGB-1; ng/ml), (B) iron (µg/dL), (C) hepcidin (ng/ml), (D) neutrophil gelatinase associated lipocalin (NGAL;
µg/ml), (E) hemopexin (mg/ml), (F) haptoglobin (mg/ml), and (G) ferritin (µg/ml). Data are expressed as mean ± SEM. n = 8–10 per group. *p < 0.05 vs. sham,
#p < 0.05 vs. FtHfl/fl.
the NF-κB-dependent gene pathway identified several genes that
were differentially regulated in the FtHLysM−/−mice (Figure 7B).
Additionally, there was a clear difference in the expression levels
of genes associated with the immune response between the
FtHLysM−/− and FtHfl/fl mice that underwent CLP (Figure 7C).
DISCUSSION
In this study we investigated whether deletion of FtH in the
myeloid cells impacts CLP-induced inflammation and organ
injury. Our findings revealed that deletion of FtH was associated
with significant disease protection against sepsis. This was
evident by lower mortality, better preserved kidney function
and blood pressure, lesser hepatic injury and serum cytokine
levels, and decreased organ inflammation in myeloid FtH
deficient mice. We found similar bacterial killing capabilities
ruling out these processes as underlying mechanisms for
the observed differences. Importantly, our results showed a
significantly higher level of serum ferritin in both sham
and CLP groups of FtHLysM−/− mice compared to their
floxed counterparts. Since the macrophages are the main
source of circulating ferritin (16), the higher serum ferritin
was likely due to consequent compensatory overexpression
of FtL in myeloid cells lacking FtH. Our in vitro and in
vivo FtL administration studies indicate that prior exposure
to FtL provides significant resistance to the septic process
by mitigating overproduction of cytokines involved in the
pathogenesis of sepsis. Our results indicate a major inhibitory
action by ferritin on NF-κB activation and its downstream
effects. RNA-Seq analyses of circulating leukocytes validate the
paramount importance of serum ferritin in inhibition of the
NF-κB pathway identifying novel functional properties of this
protein.
The exact role of iron in the pathogenesis of sepsis and
how iron regulatory proteins are involved in this process
remains under investigation (46–49). In this context, little is
known about the role of serum ferritin and its association with
sepsis, particularly its pathogenesis and outcomes. Immediately
following infection, a cascade of events shapes an environment
known as state of hypoferremia that is intended to limit
availability of iron to the infectious microbes (50, 51). This
process is primarily driven by synthesis of hepcidin which in
turn leads to endocytosis and degradation of ferroportin (52).
Other pathways that are modulated by robust elevation of
cytokines further solidify this strategy (53). The overall effect is
decreased iron absorption and increased iron retention within
reticuloendothelial cells. Serum ferritin (mainly FtL) is used to
measure body iron stores in healthy individuals but its increased
level in response to infection and inflammation limits its utility
(17, 54). The perplexing evolutionary purpose of this increase in
circulating iron poor ferritin during inflammatory processes is
yet to be fully divulged.
To understand the adaptation to sepsis induced inflammation,
we examined iron regulatory proteins that are beneficial during
sepsis. Our findings do not support such protection to be
mediated by hepcidin or NGAL, as neither of these proteins
were significantly elevated in FtHLysM−/− mice compared to
floxed controls. However, we found that serum ferritin was
strikingly high in both groups of FtHLysM−/− mice undergoing
sham or CLP surgeries. Further analysis revealed high levels
of FtL expression in macrophages of FtHLysM−/− mice that
underscores a compensatory mechanism to FtH gene deletion.
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FIGURE 6 | Ferritin light chain (FtL) mitigates LPS-induced MAPK and NF-κB activation. (A) BMDMs from FtHfl/fl mice were pre-treated with FtL for 16 h followed by
treatment with LPS or saline control. Cell lysates were collected 8 h later and analyzed for mRNA expression levels of IL-6, monocyte chemoattractant protein-1
(MCP-1), TNF-α, inducible nitric oxide synthase (iNOS), and IL-1β, Data are normalized to GAPDH and fold change relative to saline vehicle are expressed as mean ±
SEM. n = 3 from three independent experiments. *p < 0.05 vs. vehicle, #p < 0.05 vs. LPS+FtL. (B,C) FtHfl/fl BMDMs were pre-treated with FtL for 16 h, then
washed and treated with LPS and collected at 0, 0.25, 0.5, 1, 2, 4, and 8 h. Cell lysates were analyzed for expression of (B) pJNK, total JNK, pERK, FtL, and FtH.
β-actin was used as a loading control. Total ERK levels were examined in these lysates on a different membrane. (C) pP65, P65, and IκBα. GAPDH was used as a
loading control. (D) FtHfl/fl BMDMs were pre-treated with Apoferritin (ApoF) for 16 h, then washed and treated with LPS and collected at 0, 0.5, 1, 3, and 8 h. Cell
lysates were analyzed for expression of pP65, P65, IκBα, pJNK, total JNK, and FtH. GAPDH was used as a loading control. Representative western blot from one out
of three mice per treatment group.
Since the major source of circulating ferritin is FtL (16), we
postulated that this elevated serum ferritin may play a role in
inflammation during sepsis. In support of this premise, we found
a mitigated inflammatory response to LPS in macrophages with
overexpression of FtL to compensate for FtH deletion. Moreover,
when wild-type macrophages were treated with apoferritin or
recombinant FtL (all devoid of iron) we found a similar pattern
of resistance toward LPS or bacterial exposure that was evident
by lesser induction of inflammatory markers, suggesting a less
profound, and restrained response to infectious stimuli. As
expected, we found a significant increase in intracellular FtL
following administration of apoferritin and FtL. The cardinal
pathway that mediates the response of inflammatory cells to
infectious or injurious stimuli is the NF-κB pathway (40, 55). Our
in vitro findings disclose a striking blockade of this pathway with
preconditioning cells to various forms of ferritin. Also, a recent
study demonstrated that transfection of macrophages with FtL
led to reduced nuclear accumulation of p65 subunit after LPS
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FIGURE 7 | Alteration of gene expression profile of blood leukocytes following sepsis. RNA sequencing was performed on blood leukocytes isolated from FtHfl/fl and
FtHLysM−/− mice following CLP or sham surgery. (A) Hierarchical clustering of genes that are significantly altered (p < 0.01) between leukocytes from the transgenic
mice at 8 h following surgery. Heatmap displays z-transformed expression values. n = 3 per group. (B) NF-κB signaling pathway genes differentially expressed in
FtHfl/fl and FtHLysM−/− CLP compared to FtHfl/fl sham. The differentially expressed genes were identified based on absolute fold change of two or more and
adjusted p value < 0.01. n = 3 per group. (C) Genes associated with “immune response” biological process [GO: 0006955] down-regulated or differentially expressed
in FtHLysM−/− CLP compared to FtHfl/fl CLP. The differentially expressed genes were identified based on absolute fold change of two or more and adjusted p < 0.01.
n = 3 per group.
treatment (56). Given the importance of the spleen as a secondary
lymphoid organ and its role in orchestrating adaptive immune
responses, we validated the abrogation of the NF-κB pathway as
a central regulator of the phenotypes observed in FtHLysM−/−
mice. Moreover, taking advantage of the unbiased analysis of the
transcriptome of circulating leukocytes by RNA-Seq, we further
corroborate the unique signature of downregulation of the
NF-κB pathway and genes associated with “immune response”
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biological process in FtHLysM−/− mice following CLP induced
sepsis.
Our understanding of iron metabolism and role of ferritin
in various disease models is evolving. In a study published
by Lipinski et al. in 1991, it was reported that tissue ferritin
administration protects against E. coli-induced sepsis in mice
(57). Furthermore, Weis et al. recently described how FtH
mediated metabolic adaptation markedly improves disease
tolerance to sepsis (58). It is important to note that these
studies demonstrate how FtH induction plays a protective
role during sepsis by inhibiting the iron-mediated oxidative
inhibition of liver glucose-6-phosphatase and consequently
sustain adequate gluconeogenesis. In contrast, our findings
predominantly emphasize the significance of circulating FtL in
modulating inflammatory cells toward a restrained response to
infection.
It is recognized that a well-established anti-inflammatory
cytokine, IL-10, is also robustly induced during inflammation to
provide a counterbalance to an otherwise unchecked deleterious
immune response. Similar pathways have been well-described in
other physiological contexts such as the rapid induction of the
anti-coagulation pathway during activation of the coagulation
cascade. For the first time, our findings provide insight into
the elusive nature and function of circulating ferritin. These
findings suggest an important role for serum ferritin in regulating
a controlled and measured response to infection in order to
minimize a dysregulated and heightened injurious inflammatory
process that is central to the detrimental outcomes of sepsis.
These findings introduce a novel function for circulating FtL
that establishes its role as an immunomodulatory cytokine.
It must be noted that these results neither preclude utility
of serum FtL as a marker of iron stores under physiological
circumstances, nor do they rule out the association that has
been described between high levels of circulating ferritin and
worse outcomes in various inflammatory diseases (14). In
contrast, our results suggest that similar to IL-10, the increment
in the level of circulating ferritin should be regarded as an
ongoing struggle to limit the body’s inflammatory reaction
toward injurious stimuli. Notably, elevated serum ferritin is
a common finding in patients with end stage renal disease
who require renal replacement therapy. Such elevated serum
ferritin levels do not always mirror the iron status of these
patients (17). Furthermore, a significant number of these
patients dialyze via a permcath that distinctively predisposes
them to bacteremia (59–61). Hence, future studies will need
to investigate the rate of bacteremia/sepsis in these patients
and their outcomes compared to patients with normal ferritin
levels.
In summary, we provide novel findings that identify the
NF-κB pathway as a main target of circulating ferritin to
establish a restrained response to infection. These results
will provide a novel platform for future studies to better
understand the pathogenesis of sepsis and novel targets for
potentially new strategies to challenge the significant burden of
sepsis induced morbidity, mortality and substantial health care
expenditure.
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Figure S1 | Myeloid FtH deficiency prevents multi-organ failure and mortality in
experimental sepsis. Hematoxylin and eosin (HandE) staining of liver and lung
tissue from FtHfl/fl and FtHLysM−/− mice 24 h following CLP. Structural damage to
the liver is evidenced by steatosis, necrosis, and ballooning degeneration of
hepatocytes. Histologic examination of the lung demonstrates interstitial edema
and infiltration of immune cells. Scale bar = 100µm.
Figure S2 | Myeloid FtH deficiency dampens the inflammatory response following
sepsis. Spleen, liver, lung, and kidney tissues were analyzed for gene expression
levels of IL-6, IL-10, MCP-1, TNF-α, iNOS, HO-1, and FtH in FtHfl/fl and
FtHLysM−/− mice 24 h after CLP. Data are expressed as fold change relative to
GAPDH as mean ± SEM. Sham, n = 4 per group; CLP, n = 8 per group. ∗p <
0.05 vs. sham, #p < 0.05 vs. FtHfl/fl.
Figure S3 | Myeloid FtH deficiency dampens the inflammatory response without
altering the proportions of immune cell populations. (A) Representative flow
cytometry histograms of monocyte/macrophage populations from FtHfl/fl sham
control demonstrating gating scheme and proportions of immune cell populations.
(B–D) Quantification of number of cells in the (B) blood, (C) spleen, and (D) lung
24 h after CLP. Data are represented as number of cells per gram kidney (cells/g)
as mean ± SEM. n = 4–5 per group. ∗p < 0.05 vs. sham.
Figure S4 | FtH expression does not influence phagocytosis or bacterial
clearance. (A) Colony forming units (CFU) in FtHfl/fl and FtHLysM−/− mice
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peritoneal fluid 24 h after CLP. Data are expressed in CFU/mL as mean ± SEM.
n = 9–12 per group. (B) In vivo bacterial clearance was assessed by IVIS
bioluminescence. Mice were infected with E. coli Xen14 (106) intraperitoneally and
imaged. Data are expressed in photons per second (photons/sec) as mean ±
SEM. n = 7–8 per group; ∗p < 0.05 vs. 0H. (C) In vitro bacterial killing was
measured in mouse bone marrow-derived macrophages infected with E. coli
Xen14 (MOI 10 and 100). Data are expressed as mean ± SEM in A.U. n = 6 per
group. (D) In vitro phagocytic activity was assessed using pHrodo Red E. coli
BioParticles using flow cytometry. Median fluorescence intensity is expressed as
arbitrary units (A.U.) ± SEM. n = 3 per group.
Figure S5 | FtL confers protection against sepsis by mitigating NF-κB activation.
(A) FtHfl/fl BMDMs were treated with LPS with or without pre-treatment with
apoferritin or vehicle control for 16 h. Cells were collected after 8 h and analyzed
for expression of FtH, IL-6, TNF-α, NLRP3, and IL-1β mRNA. Data are normalized
to GAPDH and fold change relative to controls are expressed as mean ± SEM.
n = 6 per group. ∗p < 0.05 vs. vehicle, #p < 0.05 vs. LPS+Apoferritin.
(B) FtHfl/fl BMDMs were treated with cecal slurry (C.S.) after pretreatment with
apoferritin or saline control. Cells were collected after 8 h and analyzed for
expression of MCP-1, IL-6, TNF-α, IL-1β, and iNOS. Data are normalized to
GAPDH and fold change relative to controls are expressed as mean ± SEM. n = 5
per group. (C–E) Spleens from FtHfl/fl and FtHLysM−/− mice 24 h after CLP were
analyzed for expression of pP65, P65, and FtH. GAPDH was used as a loading
control. (D) pP65 was normalized to P65 and (E) FtH was normalized to GAPDH
and densitometric values were expressed as A.U. n = 7 per group. #p < 0.05 vs.
FtHfl/fl.
Table S1 | Serum cytokine profile of FtHfl/fl + FtL compared to FtHfl/fl.
Table S2 | Downregulated genes in FtHLysM
−/−
compared to FtHfl/fl during
sepsis.
Table S3 | Upregulated genes in FtHLysM
−/−
compared to FtHfl/fl during sepsis.
Table S4 | Primers for Real-time PCR analysis.
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